Same here.
I like what they are doing ... and hope they can commercialise what I think is a great breakthrough for ovarian cancer detection (at an early stage when it is potentially treatable with success) and turn it into a great investment.
As its a test/procedure done outside the body, obtaining FDA approval should be not as ‘difficult’ as say for a new treatment drug. More a matter of proving its clinical accuracy in detection ...ie low percentages of ‘false negatives’ and ‘false positives’.
Same here.I like what they are doing ... and hope they can...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
40.0¢ |
Change
0.030(8.11%) |
Mkt cap ! $32.64M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 40.0¢ | 37.0¢ | $33.65K | 86.60K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 16950 | 37.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.0¢ | 26783 | 2 |
View Market Depth
| Last trade - 14.18pm 30/07/2025 (20 minute delay) ? |
| COV (ASX) Chart |